Literature DB >> 24198430

Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin.

Jason R Smedberg1, Marlena M Westcott, Maryam Ahmed, Douglas S Lyles.   

Abstract

Vesicular stomatitis virus (VSV) vectors that express heterologous antigens have shown promise as vaccines in preclinical studies. The efficacy of VSV-based vaccines can be improved by engineering vectors that enhance innate immune responses. We previously generated a VSV vaccine vector that incorporates two enhancing strategies: an M protein mutation (M51R) that prevents the virus from suppressing host antiviral responses and a gene encoding bacterial flagellin (M51R-F vector). The rationale was that intracellular expression of flagellin would activate innate immune pathways in addition to those activated by virus alone. This was tested with dendritic cells (DCs) from mice containing deletions in key signaling molecules. Infection of DC with either M51R or M51R-F vector induced the production of interleukin-12 (IL-12) and IL-6 and increased surface expression of T cell costimulatory molecules. These responses were dramatically reduced in DCs from IPS-1(-/-) mice. Infection with M51R-F vector also induced the production of IL-1β. In addition, in approximately half of the DCs, M51R-F vector induced pyroptosis, a proinflammatory-type of cell death. These responses to flagellin were ablated in DCs from NLRC4(-/-) mice but not Toll-like receptor 5-deficient (TLR5(-/-)) mice, indicating that they resulted from inflammasome activation. These results demonstrate that flagellin induces additional innate immune mechanisms over those induced by VSV alone.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24198430      PMCID: PMC3911629          DOI: 10.1128/JVI.02898-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice.

Authors:  Kristen N Delaney; James P Phipps; John B Johnson; Steven B Mizel
Journal:  Viral Immunol       Date:  2010-04       Impact factor: 2.257

Review 2.  Effects of flagellin on innate and adaptive immunity.

Authors:  Anna N Honko; Steven B Mizel
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.

Authors:  L Lefrancois; D S Lyles
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

Review 4.  Viral vectors as vaccine platforms: deployment in sight.

Authors:  Christine S Rollier; Arturo Reyes-Sandoval; Matthew G Cottingham; Katie Ewer; Adrian V S Hill
Journal:  Curr Opin Immunol       Date:  2011-04-20       Impact factor: 7.486

Review 5.  The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

Authors:  Miriam Merad; Priyanka Sathe; Julie Helft; Jennifer Miller; Arthur Mortha
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

6.  Oncolytic vesicular stomatitis virus induces apoptosis via signaling through PKR, Fas, and Daxx.

Authors:  Daniel F Gaddy; Douglas S Lyles
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

7.  Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge.

Authors:  Jennifer A Schwartz; Linda Buonocore; Amorsolo L Suguitan; Alex Silaghi; Darwyn Kobasa; Gary Kobinger; Heinz Feldmann; Kanta Subbarao; John K Rose
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

8.  Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.

Authors:  Christine B Turley; Richard E Rupp; Casey Johnson; David N Taylor; Julie Wolfson; Lynda Tussey; Uma Kavita; Lawrence Stanberry; Alan Shaw
Journal:  Vaccine       Date:  2011-05-30       Impact factor: 3.641

Review 9.  Inflammasome activation via intracellular NLRs triggered by bacterial infection.

Authors:  Yukiko Koizumi; Claudia Toma; Naomi Higa; Toshitsugu Nohara; Noboru Nakasone; Toshihiko Suzuki
Journal:  Cell Microbiol       Date:  2011-11-10       Impact factor: 3.715

10.  Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cells.

Authors:  Maryam Ahmed; Kristina L Brzoza; Elizabeth M Hiltbold
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

View more
  5 in total

1.  A novel oncolytic virus engineered with PD-L1 scFv effectively inhibits tumor growth in a mouse model.

Authors:  Chuanjian Wu; Manman Wu; Minglong Liang; Sidong Xiong; Chunsheng Dong
Journal:  Cell Mol Immunol       Date:  2019-07-30       Impact factor: 11.530

Review 2.  Inflammasomes and adaptive immune responses.

Authors:  Katherine A Deets; Russell E Vance
Journal:  Nat Immunol       Date:  2021-02-18       Impact factor: 25.606

3.  Novel Immunomodulatory Flagellin-Like Protein FlaC in Campylobacter jejuni and Other Campylobacterales.

Authors:  Eugenia Faber; Eugenia Gripp; Sven Maurischat; Bernd Kaspers; Karsten Tedin; Sarah Menz; Aleksandra Zuraw; Olivia Kershaw; Ines Yang; Silke Rautenschlein; Christine Josenhans
Journal:  mSphere       Date:  2015-12-02       Impact factor: 4.389

Review 4.  Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".

Authors:  Michael Karl Melzer; Arturo Lopez-Martinez; Jennifer Altomonte
Journal:  Biomedicines       Date:  2017-02-10

5.  Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin.

Authors:  Marlena M Westcott; Jason Smedberg; Matthew J Jorgensen; Shelby Puckett; Douglas S Lyles
Journal:  Vaccines (Basel)       Date:  2018-03-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.